US Tech 100

18,919.76

1.21%

REVB Revelation Biosciences Inc

2.92

-0.01 (-0.34%)

Apr 25 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Revelation Biosciences (NASDAQ:REVB)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more Revelation Biosciences Charts.

Revelation Biosciences (NASDAQ:REVB)
Historical Stock Chart
From Apr 2024 to Apr 2025

Revelation Biosciences Inc News

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
Monday 17 March 2025 (1 month ago) • Business Wire

Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients
Wednesday 26 February 2025 (2 months ago) • Business Wire

Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval
Monday 24 February 2025 (2 months ago) • Business Wire

Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025
Friday 24 January 2025 (3 months ago) • Business Wire

Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients
Tuesday 21 January 2025 (3 months ago) • Business Wire

Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025
Monday 13 January 2025 (3 months ago) • Business Wire

Nasdaq Grants Revelation Biosciences Inc. Continued Listing
Monday 6 January 2025 (4 months ago) • Business Wire

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds
Tuesday 3 December 2024 (5 months ago) • Business Wire

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND
Monday 2 December 2024 (5 months ago) • Business Wire

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
Tuesday 12 November 2024 (5 months ago) • Business Wire

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024
Friday 8 November 2024 (6 months ago) • Business Wire

Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10
Tuesday 24 September 2024 (7 months ago) • Business Wire

More Revelation Biosciences Inc News Articles

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

REVB Revelation Biosciences Inc

Revelation Biosciences Inc News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

REVB Revelation Biosciences Inc

Revelation Biosciences Inc News

Your Recent History

Company

Business

Popular

Get The App

Sign up for an ADVFN account below

Go Ad-Free